These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34514998)

  • 41. Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma).
    Sun Y; Luo J; Chen Y; Cui J; Lei Y; Cui Y; Jiang N; Jiang W; Chen L; Chen Y; Kuang Y; Tang K; Ke Z
    Int Immunopharmacol; 2020 Mar; 80():106198. PubMed ID: 31954274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
    Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
    Front Immunol; 2018; 9():2341. PubMed ID: 30364127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TIGIT-CD155 Interactions in Melanoma: A Novel Co-Inhibitory Pathway with Potential for Clinical Intervention.
    Mahnke K; Enk AH
    J Invest Dermatol; 2016 Jan; 136(1):9-11. PubMed ID: 26763417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy.
    Wang D; Gu Y; Yan X; Huo C; Wang G; Zhao Y; Teng M; Li Y
    Front Oncol; 2022; 12():844260. PubMed ID: 35433470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155.
    Ravens I; Seth S; Förster R; Bernhardt G
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1364-71. PubMed ID: 14652024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells.
    Kamran N; Takai Y; Miyoshi J; Biswas SK; Wong JS; Gasser S
    PLoS One; 2013; 8(1):e54406. PubMed ID: 23349877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD155 and its receptors in cancer immune escape and immunotherapy.
    Zhou R; Chen S; Wu Q; Liu L; Wang Y; Mo Y; Zeng Z; Zu X; Xiong W; Wang F
    Cancer Lett; 2023 Oct; 573():216381. PubMed ID: 37660884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Artesunate-induced ATG5-related autophagy enhances the cytotoxicity of NK92 cells on endometrial cancer cells via interactions between CD155 and CD226/TIGIT.
    Zhang J; Zhou L; Xiang JD; Jin CS; Li MQ; He YY
    Int Immunopharmacol; 2021 Aug; 97():107705. PubMed ID: 33933849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blocking TIGIT/CD155 signalling reverses CD8
    Liu L; Wang A; Liu X; Han S; Sun Y; Zhang J; Guo L; Zhang Y
    J Transl Med; 2022 Jun; 20(1):280. PubMed ID: 35729552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.
    Stanietsky N; Simic H; Arapovic J; Toporik A; Levy O; Novik A; Levine Z; Beiman M; Dassa L; Achdout H; Stern-Ginossar N; Tsukerman P; Jonjic S; Mandelboim O
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17858-63. PubMed ID: 19815499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration.
    Triki H; Charfi S; Bouzidi L; Ben Kridis W; Daoud J; Chaabane K; Sellami-Boudawara T; Rebai A; Cherif B
    Life Sci; 2019 Aug; 231():116543. PubMed ID: 31176775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts.
    Oda T; Ohka S; Nomoto A
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1253-64. PubMed ID: 15194502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
    Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
    Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The N-linked glycosylations of TIGIT Asn
    Lin YX; Hung MC; Hsu JL; Hsu JM
    Biochem Biophys Res Commun; 2021 Jul; 562():9-14. PubMed ID: 34030043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complexes of poliovirus serotypes with their common cellular receptor, CD155.
    He Y; Mueller S; Chipman PR; Bator CM; Peng X; Bowman VD; Mukhopadhyay S; Wimmer E; Kuhn RJ; Rossmann MG
    J Virol; 2003 Apr; 77(8):4827-35. PubMed ID: 12663789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.
    Shibuya A; Shibuya K
    Int Immunol; 2021 Nov; 33(12):687-692. PubMed ID: 34694361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.
    Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A
    Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Limited Impact of the Inhibitory Receptor TIGIT on NK and T Cell Responses during
    Aldridge DL; Phan AT; de Waal Malefyt R; Hunter CA
    Immunohorizons; 2021 Jun; 5(6):384-394. PubMed ID: 34088852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
    Chandramohan V; Bryant JD; Piao H; Keir ST; Lipp ES; Lefaivre M; Perkinson K; Bigner DD; Gromeier M; McLendon RE
    Arch Pathol Lab Med; 2017 Dec; 141(12):1697-1704. PubMed ID: 28829151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).
    Pende D; Spaggiari GM; Marcenaro S; Martini S; Rivera P; Capobianco A; Falco M; Lanino E; Pierri I; Zambello R; Bacigalupo A; Mingari MC; Moretta A; Moretta L
    Blood; 2005 Mar; 105(5):2066-73. PubMed ID: 15536144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.